Indivior Pharmaceuticals, Inc. (INDV) Gross margin 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) gross margin by fiscal year — reported gross profit divided by reported revenue.
80.2%FY2025 · since FY2022: 83.1% → 80.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 80.2% | -0.3 pp |
| FY2024 | 80.6% | -3.5 pp |
| FY2023 | 84.1% | +1.0 pp |
| FY2022 | 83.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice